Actavis Completes Warner Chilcott Acquisition - Creates Leading Global Specialty Pharmaceutical Company - - $11.0 Billion Anticipated Pro Forma Combined 2013 Revenue - - Top 3 U.S. ~$3.0 Billion...
Actavis and Warner Chilcott Receive Approval from Irish High Court For Pending Warner Chilcott Acquisition PR Newswire PARSIPPANY, N.J. and DUBLIN, Sept. 30, 2013 PARSIPPANY, N.J. and DUBLIN...
Actavis and Warner Chilcott Receive U.S. FTC Clearance for Actavis' Proposed Acquisition of Warner Chilcott PR Newswire PARSIPPANY, N.J. and DUBLIN, Sept. 27, 2013 PARSIPPANY, N.J. and DUBLIN...
THIS ANNOUNCEMENT IS BEING MADE SOLELY TO COMPLY WITH THE REQUIREMENTS OF THE IRISH TAKEOVER RULES. THE INFORMATION SET OUT HEREIN CONCERNING THE RESULTS OF WARNER CHILCOTT'S SHAREHOLDER...
Actavis and Warner Chilcott Shareholders Approve Proposals Related to Actavis' Proposed Acquisition of Warner Chilcott PR Newswire PARSIPPANY, N.J. and DUBLIN, Sept. 10, 2013 PARSIPPANY, N.J. and...
DUBLIN, Ireland, Aug. 29, 2013 (GLOBE NEWSWIRE) -- Warner Chilcott plc (Nasdaq:WCRX) today announced that all three leading independent proxy advisory firms — Institutional Shareholder...
Actavis' Proposed Acquisition of Warner Chilcott Recommended for Approval by Leading Proxy Advisory Firms PR Newswire PARSIPPANY, N.J., Aug. 29, 2013 PARSIPPANY, N.J., Aug. 29, 2013 /PRNewswire/...
Actavis Receives Approval from French Competition Authority for Pending Warner Chilcott Acquisition PR Newswire PARSIPPANY, N.J. and DUBLIN, Aug. 9, 2013 PARSIPPANY, N.J. and DUBLIN, Aug. 9, 2013...
Actavis and Warner Chilcott Announce Effectiveness of Registration Statement on Form S-4 -- Companies Schedule Shareholder Meetings for September 10, 2013 -- PR Newswire PARSIPPANY, N.J. and...
DUBLIN, Ireland, July 24, 2013 (GLOBE NEWSWIRE) -- Warner Chilcott plc (Nasdaq:WCRX) today announced its results for the quarter ended June 30, 2013. Total revenue in the quarter ended June 30...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales